CUBEBIO is a Korean biomedical company conducting a global business by specializing in developing in-vitro diagnostic devices to discern the existence of cancers and epidemic diseases. Our product portfolio ranges from cancer screening device using urine as a specimen to COVID-19 test kits and other healthcare product lines (Sterilizations, Pet diagnosis, Smart childcare, etc)

Our product can detect the presence or absence of six cancers (pancreatic, breast, colon, lung, stomach, and liver) utilizing urine and derive results within 20 minutes.

The first screening for cancer is affordable, and a simple method for users to screen cancer is guaranteed for easy performance. In addition, the specimens are collected in a non-invasive method, hence why regular checkups are possible without any physical burdens such as pain or side effects.

By adopting a more simple, quick, and accurate screening method, CUBEBIO aims to lower the hurdles for cancer screening and increase the survival rate of cancer patients through early screening and regular health checkups.